Herpes zoster

British Medical Journal

Volumn 334, Issue 7605, 2007, Pages 1211-1215

  Wareham, David W ^a   Breuer, Judith ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACETYLSALICYLIC ACID; ACICLOVIR; AMITRIPTYLINE; CAPSAICIN; DESIPRAMINE; DICLOFENAC; FAMCICLOVIR; GABAPENTIN; INDOMETACIN; LIDOCAINE; LORAZEPAM; MAPROTILINE; METHADONE; MORPHINE; NORTRIPTYLINE; OXYCODONE; PLACEBO; PREDNISOLONE; PREGABALIN; VALACICLOVIR; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; NARCOTIC ANALGESIC AGENT;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; DRUG FORMULATION; HERPES ZOSTER; HUMAN; MEDICAL PRACTICE; PAIN; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; REVIEW; ACUTE DISEASE; EVIDENCE BASED MEDICINE; RISK FACTOR; VIROLOGY;

ACUTE DISEASE; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; ANTIVIRAL AGENTS; EVIDENCE-BASED MEDICINE; HERPES ZOSTER; HUMANS; NEURALGIA, POSTHERPETIC; OXYCODONE; PAIN; RISK FACTORS;

EID: 34250366726     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39206.571042.AE     Document Type: Review

References (25)

1. Davies L, Cossins L, Bowsher D, Drummond M. The cost for treatment of post-herpetic neuralgia in the UK. Pharmacoeconomics 1994;6:142-8.
2. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis Proc R Soc Med 1965;58:9-20.
3. Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, et al. Latent varicella zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990;323:627-31.
4. Whitley RJ. Varicella zoster. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2004.
5. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004;62:1545-51.
6. Scott FT, Leedham-Green ME, Barrett-Muir WY, Hawrami K, Gallagher WJ, Johnson R, et al. A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol 2003;70:S24-30.
7. Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 2001;19:3076-90.
8. Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J. The burden of herpes zoster: a prospective population based study. Vaccine 2006;24:1308-14.
9. Shen MC, Lin HH, Lee SS, Chen YS, Chiang PC, Liu YC. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect 2004;37:75-81.
10. Shafran SD, Tyring SK, Ashton R, Decroix J, Forszpaniak C, Wade A, et al. Once, twice or three times daily famciclovir compared with acyclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized multicenter, double-blind clinical trial. J Clin Virol 2004;29:248-53.
11. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta analysis. Arch Intern Med 1997;157:909-12.
12. Alper BS, Lewis R. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? A systematic review of the literature. J Fam Pract 2000;49:255-64.
13. Wassilew S, Collaborative Brivudin PHN Study Group. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients: a randomized double-blind, multinational study. J Eur Acad Dermatol Venereol 2005;19:47-55.
14. Wassilew SW, Wutzler P, Brivudin Herpes Zoster Study Group. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentred study. Antiviral Res 2003;59:49-56.
15. Wassilew SW, Wutzler P, Brivudin Herpes Zoster Study Group. Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antiviral Res 2003;59:57-60.
16. British Society for the Study of Infection. Guidelines for the management of shingles: report of a working group of the British Society for the Study of Infection. J Infect 1995;30:193-200
17. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44:S1-26.
18. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al. Aciclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med 1996;125:376-83.
19. Van Wijck AJ, Opstelten W, Moons KG, van Essen GA, Stolker RJ, Kalkman CJ, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 2006;367:219-24.
20. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000;44:910-8.
21. Bowsher D. The effects of pre-emptive treatment of post-herpetic neuralgia with amitriptyline: a randomised, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997;13:327-31.
22. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double blind, placebo-controlled trial. Pain 2003;104:323-31.
23. Berry JD, Petersen KL. A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005;65:444-7.
24. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 2005;191:2002-7.
25. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.